Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value:
$165.88M
Total Bought:
$50.59M
Total Sold:
$32.55M
Net Transaction:
+$18.04M
Notable People:
Tony Michael Berta
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Rhythm Pharmaceuticals, Inc.(RYTM)825,500922,100+96,600$35.77M$37.86M22.82%+$2.09M
argenx SEADR(ARGX)82,00082,150+150$32.29M$35.33M21.30%+$3.04M
Axsome Therapeutics, Inc.(AXSM)132,437290,772+158,335$10.57M$23.41M14.11%+$12.84M
Avadel Pharmaceuticals Plc01,138,178+1,138,178$0$16.00M9.65%+$16.00M
Protagonist Therapeutics Inc280,301355,000+74,699$8.11M$12.30M7.42%+$4.19M
Cytokinetics, Incorporated(CYTK)190,000190,0000$13.32M$10.29M6.21%-$3.03M
Phathom Pharmaceuticals, Inc.(PHAT)445,161875,000+429,839$4.73M$9.01M5.43%+$4.28M
Corcept Therapeutics Incorporated(CORT)273,776244,750-29,026$6.90M$7.95M4.79%+$1.06M
Atyr Pharma Inc1,446,4771,946,477+500,000$2.82M$3.04M1.83%+$215.9K
Pliant Therapeutics, Inc.(PLRX)0232,200+232,200$0$2.50M1.50%+$2.50M
Kymera Therapeutics, Inc.(KYMR)082,000+82,000$0$2.45M1.48%+$2.45M
Cidara Therapeutics Inc0145,417+145,417$0$1.74M1.05%+$1.74M
Trevi Therapeutics, Inc.(TRVI)506,082500,089-5,993$1.75M$1.49M0.90%-$255.7K
Applied Therapeutics Inc220,000227,470+7,470$1.50M$1.06M0.64%-$433.7K
Soleno Therapeutics Inc019,695+19,695$0$803.6K0.48%+$803.6K
Allakos Inc767,964649,957-118,007$967.6K$650.0K0.39%-$317.7K
Atara Biotherapeutics Inc892,8530-892,853$619.6K$0—-$619.6K
Avadel Pharmaceuticals PlcADR701,3870-701,387$11.85M$0—-$11.85M
GH Research PLC(GHRS)185,6530-185,653$1.98M$0—-$1.98M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)618,5280-618,528$5.39M$0—-$5.39M
Mirum Pharmaceuticals, Inc.(MIRM)362,1930-362,193$9.10M$0—-$9.10M
Verastem, Inc.(VSTM)168,7390-168,739$1.99M$0—-$1.99M
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q2 2024 | TickerTrail